18th Annual U.S. Patient Conference

Join us September 7-10th in Disney Springs, FL

We can’t wait for Clusterbusters 18th Annual U.S. Patient Conference in Disney Springs, FL! Join the cluster community for a long weekend of support, education, and family from Sept 7 – 10, 2023.

Register

Share your experience

Take our survey on psychedelics, medicines, alternative substances and devices.

Clusterbusters & UTHealth Houston are excited to share our comprehensive Cluster Headache Medication & Psychedelic Use Survey. The results will help advance research for cluster headache treatments. This survey is anonymous.

For questions contact Mark Burish MD PhD

Take Survey

Have you been diagnosed with New Daily Persistent Headache?

Take the NDPH Patient Experience Survey.

Share your New Daily Persistent Headache experience anonymously with the #NDPH Patient Experience Survey. It’s a collaboration of NDPHaware.org and UTHealth Houston. Your voice will improve research and access to appropriate treatments.

Take Survey

Initial Results: Clinical Trial of Psilocybin for Cluster Headache

The first results of a small randomized controlled study of psilocybin for cluster headache have been published in the journal Headache.

Cluster headache epidemiology including pediatric-onset, sex, and ICHD criteria.

International Cluster Headache Questionnaire Results

New Study at Yale

Personal and Environmental Factors in Cluster Headache Attacks

Learn More

Psilocybin and Migraine Disease

Joint research project by Clusterbusters INC. and Cluster Headache – Trigeminal Autonomic Cephalahia (CH-TAC), LLC

Learn More

High-Flow Oxygen Therapy for Cluster Headaches

Oxygen is an essential tool for dealing with cluster headaches (CH). For most people with CH, oxygen when properly used will abort an attack within 15 minutes—often in less time than that. Unlike many other prescribed abortive medications and treatments, oxygen has no negative side effects

Learn More